Belosalik Ointment for external use, 40 g

Belosalik ointment for plank beds.

approx.

40g

Name ENG

BELOSALIC

Clinical and pharmacological group

Drug with anti-inflammatory and keratolytic action for external use

ATX code

Betamethasone in combination with other drugs

Dosage

0.05% + 3% x 40g

Structure

1 g of ointment contains:

.Active substances: betamethasone dipropionate - 640 mcg, which corresponds to the content of betamethasone - 500 mcg

salicylic acid 30 mg.

.Auxiliary substances: mineral oil, petroleum jelly.

Indications

Subacute and chronic dermatoses, in which therapy with topical corticosteroids is effective, and accompanied by hyperkeratosis and desquamation, including:

Psoriasis.

Eczema (dyshidrotic, seborrheic, tylotic).

Neurodermatitis.

Lichen planus.

Asbestos lichen.

Chronic discoid lupus erythematosus.

Ichthyosis and ichthyosis skin lesions.

Seborrhea.

Seborrheic dermatitis (scalp).

The drug in the form of a solution for external use is indicated for use on the scalp, as well as in children 6 months of age and older.

INN / Active ingredient

Betamethasone dipropionate, salicylic acid

Storage conditions and periods

At a temperature not higher than 25 degrees.

Expiration date: 4 years

Contraindications

Lupus.

Cutaneous manifestations of syphilis.

Chickenpox.

Viral skin infections.

Post-vaccination skin reactions.

Open wounds.

Trophic ulcers.

Rosacea.

Acne vulgaris.

Children under 6 months of age (for ointment).

Hypersensitivity to betamethasone, salicylic acid, or to any of the auxiliary components of the drug.

Specifications

Category

Psoriasis

Scope of the drug

Leather

,

Dermatology

Release form

Ointment

Manufacturer country

Croatia

Package quantity, pcs

one

Scope of application

Dermatology

Minimum age from

6 months

Way of introduction

Outwardly

Vacation conditions

Without recipe

Brand name

Belupo

The amount of the dosage form in the primary package

40 g

Primary packaging type

Tuba

Type of consumer packaging

Pack of cardboard

Anatomical and therapeutic characteristics

D07XC01 Betamethasone, in combination with other drugs

Dosage form

Ointment for external use

Expiration date in days

1461

Package weight, g

fifty

Mode of application

:

The drug is intended for external use.

< br> A small amount of ointment is evenly distributed over the surface of the skin, rubbing lightly.

Frequency rate of application - 2 times / day, in mild cases, a single use is sufficient.

< br> The duration of a continuous course of treatment is usually limited to 3-4 weeks.

If a longer course of therapy is required, it is recommended to use the drug less often, for example, every other day.

In the treatment of chronic diseases, treatment should be continued for some time after the disappearance of all symptoms, under the supervision of a doctor, in order to avoid a relapse of the disease.

< br> Repeated courses of therapy are possible during the year.

Pharmaco-therapeutic group

:

Topical glucocorticosteroid + keratolytic agent

Dosage (volume) of the substance in the preparation

:

Betamethasone dipropionate - 640 mcg, which corresponds to the content of betamethasone - 500 mcg

salicylic acid 30 mg